{"lastClose": 3.7200000286102295, "len": 995, "date": "2023-03-16", "alpha_1": -0.7971949599283461, "beta_1": 0.8556264054683721, "drawup_1": 0.7155424508464454, "natr_1": 21.90954569027678, "sup_1": -0.7598566053257968, "res_1": 0.9130824567444931, "bullPattern_1": ["INVERTEDHAMMER"], "bearPattern_1": ["SHORTLINE"], "rsi_1": 29.56989085361371, "adx_1": 23.288244810345383, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.7040073094644695, "stratHoldAlpha_1": 250.40794591952817, "stratHoldDrawdown_1": -0.740608224572233, "alpha_3mo": -0.5839916380705693, "beta_3mo": 1.386921498475816, "drawup_3mo": 0.20805376931257258, "natr_3mo": 21.90954569027678, "sup_3mo": -0.05017922732000022, "res_3mo": 0.07706092190695638, "bullPattern_3mo": ["INVERTEDHAMMER"], "bearPattern_3mo": [], "rsi_3mo": 22.641504058439246, "adx_3mo": 61.15081465281729, "drawdown_3mo": -0.31111111797913593, "stratHoldSharpe_3mo": -1.8292431939112168, "stratHoldAlpha_3mo": 250.10693247791679, "stratHoldDrawdown_3mo": -0.2828282888196728, "Name": "NGM Biopharmaceuticals Inc.", "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Sector": "Health Care", "Market Cap": 304021140, "Country": "United States", "IPO Year": 2019.0, "alpha%_1": 0.007734941738677627, "beta%_1": 0.3992468712871081, "drawup%_1": 0.674240042705541, "natr%_1": 0.9999999999979438, "drawdown%_1": 0.013124912011827394, "stratHoldSharpe%_1": 0.17621430376417635, "stratHoldAlpha%_1": 0.012149468678568908, "stratHoldDrawdown%_1": 0.012803713889092084, "alpha%_3mo": 0.12829654237310567, "beta%_3mo": 0.7468609384167217, "drawup%_3mo": 0.40306638210949725, "natr%_3mo": 0.9999999999958409, "drawdown%_3mo": 0.10101705246921394, "stratHoldSharpe%_3mo": 0.08831189653386862, "stratHoldAlpha%_3mo": 0.0391542604364522, "stratHoldDrawdown%_3mo": 0.10713357782783278}